Your browser doesn't support javascript.
loading
miR-9 and miR-200 Regulate PDGFRß-Mediated Endothelial Differentiation of Tumor Cells in Triple-Negative Breast Cancer.
D'Ippolito, Elvira; Plantamura, Ilaria; Bongiovanni, Lucia; Casalini, Patrizia; Baroni, Sara; Piovan, Claudia; Orlandi, Rosaria; Gualeni, Ambra V; Gloghini, Annunziata; Rossini, Anna; Cresta, Sara; Tessari, Anna; De Braud, Filippo; Di Leva, Gianpiero; Tripodo, Claudio; Iorio, Marilena V.
Afiliação
  • D'Ippolito E; Start Up Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Plantamura I; Start Up Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Bongiovanni L; Tumor Immunology Unit, Department of Health Sciences, University of Palermo, Palermo, Italy.
  • Casalini P; Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Baroni S; Start Up Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Piovan C; Start Up Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Orlandi R; Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Gualeni AV; Department of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Gloghini A; Department of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Rossini A; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Cresta S; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Tessari A; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • De Braud F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy.
  • Di Leva G; Environment & Life Sciences, University of Salford, Salford, United Kingdom.
  • Tripodo C; Tumor Immunology Unit, Department of Health Sciences, University of Palermo, Palermo, Italy.
  • Iorio MV; Start Up Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. marilena.iorio@istitutotumori.mi.it.
Cancer Res ; 76(18): 5562-72, 2016 09 15.
Article em En | MEDLINE | ID: mdl-27402080
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptor beta de Fator de Crescimento Derivado de Plaquetas / MicroRNAs / Neoplasias de Mama Triplo Negativas / Neovascularização Patológica Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptor beta de Fator de Crescimento Derivado de Plaquetas / MicroRNAs / Neoplasias de Mama Triplo Negativas / Neovascularização Patológica Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article